Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 3, 2015Brain and BehaviorOpen Access

An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis

View Full Paper
Ask AI
Bookmark
Share

Authors

NGNeeta GargUniversity of MinnesotaTSThomas W. SmithBoston University

Discussion

Loading...

Member takes

Implication

Narrative review reveals advances in etiology, diagnosis, and immunomodulatory treatment for multiple sclerosis, highlighting evolving therapeutic options.

Key Points

  • To review and update current clinical knowledge on the etiology, immunopathogenesis, diagnosis, and immunomodulatory therapy of multiple sclerosis.
  • Synthesized biomedical literature addressing the underlying mechanisms and triggers of multiple sclerosis.
  • Evaluated contemporary diagnostic protocols and emerging immunomodulatory therapeutic strategies.
  • Identifies key immune pathways and pathological factors driving central nervous system inflammation and demyelination.
  • Outlines advancements in diagnostic criteria and the therapeutic potential of targeted immunomodulatory interventions.

Cite This Study

Garg et al. (2015) studied this question.

synapsesocial.com/papers/69d84392ba18484428d188f6https://doi.org/10.1002/brb3.362
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Management of Multiple Sclerosis1997 · 203 citations
  2. 2Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis2001 · 6,985 citations
  3. 3PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy2013 · 185 citations
  4. 4Update on immunopathogenesis and immunotherapy in multiple sclerosis2013 · 34 citations
  5. 5Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 · 1,738 citations